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Intestinal stem cells hold great potential in tissue regeneration of the intestine,  
however there are key limitations in their culture in vitro. We previously reported a 
novel synthetic non-biodegradable hydrogel as a 3D culture model for intestinal 
epithelium using Caco2 and HT29-MTX cells. Here, we investigated the potential of 
this system as a 3D scaffold for crypts and single intestinal stem cells to support 
long-term culture and differentiation.  
Intestinal crypts were extracted from murine small intestines and Lgr5+ stem cells 
isolated by magnetic activated cell sorting. Crypts and stem cells were suspended 
within Matrigel or L-pNIPAM for 14 days or suspended within Matrigel for 7 days then 
released, dissociated, and suspended within, or on L-pNIPAM hydrogel for 28 days. 
Cellular behaviour and phenotype were determined by histology and 
immunohistochemistry for stem cell and differentiation markers: Lgr5, E-cadherin 
MUC2 chromograninA and lysozymes.   
Isolated crypts and Lgr5+ intestinal stem cells formed enteroids with a central lumen 
surrounded by multiple crypt-like buds when cultured in Matrigel. In contrast, when 
crypts and stem cells were directly suspended within, or layered on L-pNIPAM 
hydrogel under dynamic culture conditions they formed spherical balls of cells, with 
no central lumen. When enteroids were innitially formed in Matrigel from crypts or 
single Lgr5+ intestinal stem cells and dissociated into small fragments or single cells 
and transferred to L-pNIPAM hydrogel they formed new larger enteroids with 
numerous crypt-like buds. These crypt-like buds showed the presence of mucin-
producing cells, which resembled goblet cells, scattered throughout their structures. 
Immunohistochemistry staining also showed the expression of Lgr5 and 
differentiation markers of all the main intestinal cell types including: enterocytes, 
goblet cells, enteroendocrine and Paneth cells. This demonstrated that L-pNIPAM 
hydrogel supported long-term culture of crypts and Lgr5+ stem cells and promoted 
intestinal cell differentiation.   
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The intestinal mucosa is composed of columnar epithelia which form intestinal villi 
and crypts. These crypts are the site of intestinal stem cell (ISC) production[1]. The 
intestinal epithelium rapidly self-renews every 3-5 days[2]. This is driven by three cell 
types:  intestinal stem cells, crypt base columnar cells (CBCs), which reside at the 
bottom of the intestinal crypts; and Paneth cells which support and contribute to the 
stem cell niche[3, 4]. The stem cells within crypts are capable of responding to local 
environmental changes ensuring that the correct cellular populations are produced 
within the villi. Hence, the cells within the stem cell niche regulate villus cell 
proliferation and the stem cell population[5-8]. The stem cell population expresses a 
leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5), which is a target 
gene for WNT signalling[2]. Hence a single Lgr5 positive stem cell (Lgr5+) is capable 
of regenerating all the cell types within the intestinal epithelium[2, 9-11]. 
It has previously been shown that when small intestinal crypt cells, isolated from 
mice, are embedded within Matrigel, and cultured in the presence of R-spondin 1, 
Noggin, and epidermal growth factors, cells expanded in culture without significant 
genetic or physiologic alterations[12-15]. Under these conditions, cells organised 
themselves into 3D tissue constructs described as enteroids. These consist of a 
central sphere-shaped domain, composed mostly of differentiated cells, and 
numerous bud-like structures similar to that of an intestinal crypt. A noticeable 
feature of the epithelial enteroid system is its ability to grow cells almost infinitely 
from a small number of cells, or tiny pieces of tissue[16-18]. Similarly, single isolated 
Lgr5+ stem cells grown in Matrigel culture also formed enteroids. These enteroids 
contained crypt and villus domains which recapitulate essential processes of the 
native intestinal epithelium[19-21]. Wang et al (2017) reported that when pre-isolated 
stem cells or crypts from the human small intestine were cultured within Matrigel they 
formed cystic-enteroids[22]. These cystic-enteroids formed an enclosed lumen 
surrounded by a single layer of non-polarized epithelial cells made up of both 
proliferating cells randomly mixed with differentiated cells. These cystic-enteroids did 
not reflect the tissue of the intestine in vivo and were unsuitable for studying 
intestinal functions. This led to the development of alternative scaffolds to support 
the growth of intestinal stem cells. Those which were investigated previously, 
including type 1 collagen gels, which support long-term (28 days) maintenance and 
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expansion of enteroids formed from co-culture of human small intestinal crypts with 
intestinal sub-epithelial myofibroblasts [23]. Similarly, Sachs et al (2017) showed that 
mice intestinal enteroids could be formed from a single Lgr5+ stem cell, when 
embedded in Matrigel for 3 days. These enteroids, when released from Matrigel and  
grown in a floating tube of type 1 collagen were shown to align, fuse and self-
organize into a hollow tube-like structures which became lined with the stem cells 
and differentiated into the major types of intestinal epithelial cells[24].  
Although these enteroid systems have had a huge impact on intestinal research, the 
size, structure, and function of epithelial components in these enteroids are not 
comparable to those seen in vivo. For example, differentiated epithelial cells in small 
intestinal enteroids fail to form finger-like structures, that accurately mimic native 
intestinal villi [25]. This has led to the use of a variety of bio-fabrication techniques to 
produce functional intestine which attempts to mimic the villus-crypt architecture of 
the intestine in vivo. A recent study, demonstrated that micro-engineered collagen 
scaffolds with appropriate extracellular matrix and stiffness (modulus young's = 
approximately 10 KPa) generated an in vitro human small intestinal epithelium with a 
polarized monolayer which mimicked in vivo crypt-villus structure with a suitable cell 
lineage and an open luminal surface[22]. Although current enteroid culture systems 
are dependent on animal-derived hydrogels such as Matrigel and collagen gels, 
these scaffolds are complex and vary in their composition which makes them 
inappropriate for enteroid expansion for clinical applications. Hence, this has led to 
the use of synthetic matrices in tissue engineering of the small intestine[26]. 
Cromeens et al (2016) produced tissue-engineered intestine from enteroids using a 
mixture of synthetic and natural materials. These enteroids were expanded in 
Matrigel then released and suspended in poly-glycolic acid (PGA) scaffold coated 
with type 1 collagen. This was then implanted in the peritoneal cavity of 
immunosuppressed NOD/SCID mice for 4 wks. Tissue-engineered intestine showed 
the presence of crypts and short villi, which contained all intestinal epithelial cell 
lineages, however these studies failed to recapitulate the true in vivo morphology 
having only short villi[27]. This study suggested that a synthetic extracellular matrix 
could provide a suitable scaffold for maintenance and expansion of crypts and 
intestinal stem cells. Thus, the current study investigated the tissue engineering 
potential of a novel synthetic L-pNIPAM hydrogel, which has previously 
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demonstrated the ability to support villus-like structures[28]. Here, we investigate the 
use of this 3D scaffold to support long-term culture of crypt cells and Lgr5+ intestinal 
stem cells under dynamic culture conditions. The capacity of these cells to 
differentiate into intestinal epithelial cells in vitro when suspended within or layered 
on L-pNIPAM hydrogel was also investigated. 
MATERIALS AND METHODS 
Mice 
BALB/c mice (Charles River Laboratories) aged 6-12 weeks old were used for the 
extraction of intestinal crypts and isolation of single Lgr5+ stem cells. No live animals 
were used in our experiments. 
Culture media 
The basal culture media (Advanced Dulbecco's Modified Eagle Medium (DMEM/F12) 
(Life Technologies, Paisley, UK) supplemented with 100 µg/ml penicillin/ 
streptomycin (Life Technologies, Paisley, UK), 250 ng/ml amphotericin (Sigma, 
Poole, UK), 2 mM glutamine (Life Technologies, Paisley, UK), and 1 M HEPES 
buffer (Sigma, Poole, UK)). The crypt basal media was made by supplementing with 
B-27 (50 x) (Life Technologies, Paisley, UK), N-2 (100 x) (Life Technologies, Paisley, 
UK), and 0.5 M N-Acetyl-L-cysteine (Sigma, Poole, UK). 
Small intestinal crypt extraction 
Isolation of small intestinal crypts was performed as described previously[17, 29, 30]. 
Briefly, the duodenum and jejunum were collected and flushed with ice-cold washing 
solution (10% (v/v) heat-inactivated foetal bovine serum (FBS) (Life Technologies, 
Paisley, UK) in PBS without Ca2+ and Mg2+ (Life Technologies, Paisley, UK)) using a 
10 ml syringe fixed with a 18 gauge needle. All luminal content was removed. In 
order to extract the crypts, dissected intestines were opened lengthwise and villi of 
intestines were scraped off using a coverslip, and discarded. The rest of the intestine 
(including the crypts) were washed with washing buffer and cut with scissors into 2-4 
mm pieces. These pieces were then transferred into a 50 ml Falcon tube and further 
washed with ice-cold washing solution (approximately 10 times), and pipetting up 
and down, until the supernatant was clear. The tissue fragments were transferred 
into 50 ml falcon tubes and incubated in 25 ml of chelating buffer (2 mM EDTA 
(Sigma, Poole, UK) in PBS) on ice and shaken gently on an orbital shaker for 15 
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mins. The tubes were inverted gently, and cell fragments were allowed to settle at 
the bottom of the tubes. The chelating buffer was carefully removed and the crypts 
were re-suspended in 20 ml of washing solution for 5 min. Tissues were then passed 
through a 70 µm cell strainer to remove any remaining tissue debris and the crypt 
fraction was collected. The fraction (Fraction I) was stored on ice. The remaining 
tissue fragments were re-suspended in ice-cold washing solution, pipetted 5-10 
times and the supernatant was passed through 70 µm cell strainers (Fraction II). The 
previous step was repeated a second time and a third fraction was collected 
(Fraction III). The three fractions were pooled and centrifuged at 200 g for 5 min at 
4°C. The pellet was re-suspended in 10 ml ice-cold basal culture medium and 
centrifuged at 300 g for 5 min at 4°C to remove single cells and tissue debris. The 
number of crypts were counted under the inverted microscope. The crypts were 
subsequently either directly embedded in either Matrigel or L-pNIPAM hydrogel, or 
further dissociated into a single Lgr5+ stem cell population. 
Suspension of small intestinal crypts within Matrigel  
Matrigel (basement membrane matrix, growth factor reduced and phenol red-free) 
(Corning, UK) was mixed with growth factors (recombinant human R-Spondin 1 (1 
µg/ml) (PeproTech, London, UK), recombinant murine Noggin (100 ng/ml) 
(PeproTech, London, UK) and recombinant murine EGF (50 ng/ml) (PeproTech, 
London, UK)) on ice. One to five hundred crypts were re-suspended in 50 µl of 
Matrigel. The suspension was pipetted in the middle of the well of pre-warmed 24 
well-plates which had been allowed to cool to room temperature for 2-3 min. The 
plates were then transferred to 37°C for 15 min to allow complete polymerization of 
the Matrigel. Five hundred microliters of crypt basal media supplemented with 
epidermal growth factor (EGF) (50 ng/ml), Noggin (100 ng/ml), and R-Spondin 1 (1 
µg/ml) (ENR) was added to each well. Cultures were maintained for up to 14 days, at 
37°C, 50 mL/L CO2 in crypt basal media supplemented with ENR which was replaced 
every 48 h. 
Suspension of small intestinal crypts within L-pNIPAM hydrogel    
L-pNIPAM hydrogel was prepared as previously described[28]. One to five hundred 
crypts were re-suspended in 300 µl of liquid L-pNIPAM hydrogel at 38-39°C. The 
suspension was added in each well of a 48 well plate and allowed to cool below the 
lower critical solution temperature of the L-pNIPAM hydrogel to induce gelation. Five 
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hundred microliters of crypt basal medium supplemented with ENR was added per 
well. Cultures were maintained for up to 14 days at 37°C, 50 mL/L CO2 and under 
dynamic conditions, created using an orbital shaker set at 30 rpm. Media was 
replaced with fresh crypt basal media supplemented with ENR every 48 h. 
Layering of small intestinal crypts on L-pNIPAM hydrogel        
Three hundred microliters of L-pNIPAM was added to each well of 48 well plates. 
Following gelation 300 µl of crypt culture media containing one to five hundred crypts 
was applied to the surface of hydrogel construct. After a 30 min cell attachment 
period, 200 µl of crypt basal media was added to each well. All plates were 
maintained in culture for up to 14 days at 37°C, 50 mL/L CO2 and under dynamic 
culture conditions, created using an orbital shaker set at 30 rpm. Fresh crypt basal 
media supplemented with ENR was replenished every 48 h. 
Suspension of small intestinal crypts within Matrigel followed by suspension 
within or layered on L-pNIPAM hydrogel 
The extracted crypt pellet was suspended and cultured in Matrigel for 7 days. The 
resultant enteroids were released from Matrigel on day 7 and were either suspended 
within or layered on L-pNIPAM hydrogel. Briefly, to release enteroids completely 
from Matrigel, the media was removed from the enteroids and 500 µl of cold PBS 
was added to each well. Matrigel containing enteroids were broken up by pipetting 
up and down. The suspension was transferred into 15 ml conical tubes and the 
enteroids were pipetted up and down 50-100 times to mechanically disassociate the 
enteroids into smaller fragments, and separate them from the matrigel extracelluar 
matrix. Seven milliliters of cold PBS was added to the tube and pipetted up and 
down a further 20 times, ensuring complete washing. The suspension was 
centrifuged at 200 g for 5 min at 4°C. The pellet containing the crypt cells was either 
suspended within or layered on 300 µl of L-pNIPAM hydrogel and maintained for up 
to 14 days at 37°C, 50 mL/L CO2 under dynamic culture, created using an orbital 
shaker set at 30 rpm. Media was replaced with fresh crypt basal media 
supplemented with ENR every 48 h. 
Isolation of small intestinal stem cells 
The crypt pellet was re-suspended with 2 ml of pre-warmed single cell dissociation 
medium (basal medium supplemented with Y-27632, (10 µM/ml), which is a specific 
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inhibitor of Rho kinase (ROCK) (Sigma, Poole, UK)) for 30-45 min at 37°C until cells 
dissociated. During incubation, the crypt suspension was mechanically pipetted with 
fire-polished pasteur pipette every 5-10 min until the crypts were dissociated into 
single cells or 2-3 cell clusters. The cell suspension was filtered through 40 µm cell a 
strainer to remove any remaining cell clumps, then resuspended with basal medium 
and centrifuged at 300 g at 4°C. The pellet was re-suspended with 1 ml single-cell 
dissociation medium (basal medium supplemented with Y-27632 (10 µM/ml)), and 
centrifuged at 500 g for 10 min and the supernatant was completely removed in 
preparation of Magnetic Activated Cell Sorting (MACS).  
 
Magnetic Activated Cell Sorting (MACS)  
Following the manufacturer's protocol the cell pellet was resuspended up to 1 x 106 
nucleated cells in 45 µl of degassed MACS buffer solution (PBS plus 0.5% (w/v) 
bovine serum albumin (BSA), and 2 mM EDTA). This MACS buffer solution was 
prepared by diluting 1 ml MACS BSA stock solution (Miltenyi Biotec, UK) with 20 ml 
autoMACS rinsing solution (Miltenyi Biotec, UK). Five microlitres of FcR blocking 
reagent (Miltenyi Biotec, UK) was added to the suspension to block unwanted 
binding of Lgr5 antibody to mouse cells expressing Fc receptors (e.g. B cells, 
monocytes or macrophages); mixed well and refrigerated for 10 min at 2-8°C. Cells 
were labeled by adding 5 µl of biotinylated Lgr5 antibody (Miltenyi Biotec, UK), mixed 
well and refrigerated for 10 min. Cells were then washed by adding 1-2 ml of 
degassed MACS buffer and centrifuged at 500 g for 10 min. The supernatant was 
removed and cell pellet re-suspended in 70 µl of degassed MACS buffer. Cells were 
magnetically labeled by adding 20 µl of anti-biotin microbeads (Miltenyi Biotec, UK), 
mixed well and refrigerated for 15 min. The cells were washed in 1-2 ml of degassed 
MACS buffer and centrifuged at 500 g for 10 min. The supernatant was removed and 
cell pellet re-suspended in 500 µl of degassed MACS buffer and magnetically 
separated. 
The MACS MS column (Miltenyi Biotec, UK) was inserted into the column holder on 
the MACS separator. The column was rinsed with 500 µl of degassed buffer and the 
effluent was discarded. The magnetically labeled cell suspension was loaded onto a 
MACS MS column; unlabelled cells were flushed through the column with 3 x 500 µl 
degassed MACS buffer. The unlabelled cell fraction was collected and a new 
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collection tube was placed under the column. The column was removed from the 
magnetic holder, 1 ml of degassed MACS buffer was pipetted onto the column and 
plunger applied causing the magnetically labeled Lgr5 positive (Lgr5+) cells to be 
released and collected from the column. To increase the purity of the magnetically 
labeled fraction, the Lgr5+ fraction was applied onto a freshly prepared MS column 
as described above, and MACS sorting repeated. The number of Lgr5+ cells/ml were 
counted following sorting and cell suspensions were centrifuged at 500 g for 5 min 
and the supernatant discarded. The cell pellet was used for subsequent culture 
experiments.  
Cytospin of Lgr5+ sorted cells  
A sample of the Lgr5+ sorted cells was fixed in 40 g/L formaldehyde (Sigma, Poole, 
UK) for 20 min. The cells were centrifuged at 300 g for 5 min and resuspended in 
PBS at a cell density of 300 cells/µl. One hundred microliters of cell suspension was 
cytospun by centrifugation at 1000 rpm for 3 min (Shandon cytospin 3, Thermo 
Scientific, Loughborough, UK). Slides were then air-dried and stored at 4°C until 
needed for immunohistochemical investigation. 
  
Suspension of Lgr5+ stem cells within Matrigel 
Matrigel was mixed with growth factors: Notch ligand Jagged-1 peptide (1 µM/ml) 
(Eurogentec, Southampton, UK), and ENR on ice. One to two hundred Lgr5+ stem 
cells were re-suspended in 10 µl of Matrigel and pipetted into the middle of the well 
of a pre-warmed 96 well-plate. Following 2-3 min at room temperature, they were 
transferred to 37°C for 15 min to allow complete polymerization of the Matrigel. One 
hundred microliters of fresh crypt basal media supplemented with 2.5 µM/ml GSK3β 
inhibitor (CHIR99021) (Sigma, Poole, UK) (to activate β-catenin and other survival 
pathways), ROCK activity inhibitor (2.5 µM/ml Thiazovivin) (Sigma, Poole, UK) to 
decrease anoikis by increasing the stability of E-cadherin) (both of these 
supplements were added during the first 2 days culture only, as previously 
described[31]), and ENR was added to each well. To reduce apoptosis and promote 
the survival of single stem cells during the first 2 days of culture a Notch agonist 
Jagged-1 peptide (1 µM/ml) was also added to the cell culture media. Cultures were 
maintained for up to 14 days at 37°C, 50 mL/L CO2, and the media was replaced 
with fresh crypt basal media supplemented with ENR every 48 h.  
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Suspension of Lgr5+ stem cells within Matrigel followed by suspension within 
or layered on L-pNIPAM hydrogel 
Isolated Lgr5+ stem cells were suspended in Matrigel, the enteroids which formed 
from Lgr5+ stem cells were released from Matrigel at day 7. Briefly, media was 
removed and 100 µl of cold PBS was added to each well. Matrigel was broken up by 
pipetting up and down to mechanically disassociate the enteroid into single cells. 
The suspension was transferred into 1.5 ml Eppendorf and centrifuged at 300 g for 5 
min. The pellet was either suspended within or layered on L-pNIPAM hydrogel and 
maintained for 1 to 4 weeks at 37°C, in 50 mL/L CO2 under dynamic culture 
conditions as described above. Media was replaced with fresh crypt basal media 
supplemented with ENR every 48 h. Jagged-1 peptide (1 µM/ml) was added to the 
cell culture media during the first 2 days of culture.  
Characterisation of crypts and Lgr5+ stem cells  
Bright field images of crypts and Lgr5+ stem cells 
Crypts and Lgr5+ stem cells were suspended within Matrigel for up to 14 days. Bright 
field images were taken using an inverted microscope (Olympus IX8, UK) and 
images captured using Cell-F software. 
Histological assessment 
Crypt cells either suspended within or layered on L-pNIPAM hydrogel together with 
those Lgr5+ stem cells suspended in Matrigel for 7 days released from Matrigel and 
suspended within or layered on L-pNIPAM hydrogel were assessed. Triplicate 
samples were fixed in 40 g/L formaldehyde/PBS for 24 h prior to washing in PBS and 
processed to paraffin wax in a TP1020 tissue processor (Leica Microsystem, Milton 
Keynes, UK). Four-micron sections were cut and mounted onto positively charged 
slides (Leica Microsystem Milton Keynes, UK). Sections were stained with 




Immunohistochemistry was performed as described previously[28] to investigate: 
Adhesion junction protein (using anti-E-cadherin antibody (1:200 mouse monoclonal, 
heat antigen retrieval) (ab76005, Abcam, Cambridge, UK); MUC2 production using 
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anti-MUC2 antibody (1:100 rabbit polyclonal, heat antigen retrieval) (Santa Cruz, 
Heidelberg, Germany); Chromogranin A production as an indication of 
enteroendocrine cell presence using anti-Chromogranin A antibody (1:100 rabbit 
polyclonal, heat antigen retrieval) (ab15160, Abcam, Cambridge, UK); and  lysozyme 
production as an indication of Paneth cell presence (using anti-Lysozyme antibody 
(1:2000 rabbit monoclonal, heat antigen retrieval) (ab108508, Abcam, Cambridge, 
UK).  
RESULTS 
Morphological assessment of crypts isolated from the small intestine 
suspended within Matrigel, L-pNIPAM hydrogel or layered on L-pNIPAM 
hydrogel 
When isolated crypts were suspended in Matrigel, they formed enteroid-like 
structures within 1 day (Figure 1A). After 2 days, these structures began to develop 
crypt-like buds. Larger mature buds made up of several well-defined cells were seen 
by day 6 to 7, suggesting the presence of stem cells within the crypt buds. Between 
day 7 and 14, the enteroids enlarged with increasing number of crypt-like buds 
(Figure 1A).  
When isolated crypts were directly suspended within or layered on L-pNIPAM 
hydrogel under dynamic culture conditions, H&E staining showed that crypts failed to 
form true enteroid structures by day 10 to 14, with no appearance of crypt-like buds 
(Figure 1B). However, alcian Blue/PAS staining showed the presence of mucin-
producing goblet cells scattered throughout their structures, and the presence of an 
adherent mucus layer by day 14 (Figure 1B). 
Morphological assessment of the enteroids when released from Matrigel, 
dissociated and suspended within or layered on L-pNIPAM hydrogel 
When enteroids were formed in Matrigel for 7 days, and dissociated into small 
fragments and then transferred into or onto L-pNIPAM hydrogel they formed new 
enteroids within 10 days with numerous crypt-like buds (Figure 1C), containing 
mucin-producing cells (Figure 1C). 
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Phenotypical assessment of the enteroids derived from crypts suspended 
directly in L-pNIPAM hydrogel or in  Matrigel for 7 days then dissociated and 
re-suspended in L-pNIPAM  
Immunohistochemistry staining was used to determine the cellular composition of the 
enteroids derived from crypts suspended within L-pNIPAM hydrogel following 10 
days culture (Figure 2A-E) or derived from dissociated enteroids re-suspended and 
cultured within L-pNIPAM hydrogel (Figure 2F-J). The stem cell marker Lgr5 
expression was within the crypt-like structure of all enteroids; this was expressed 
alongside markers for all terminally differentiated epithelial cell lineages which 
identified the presence of enterocytes, goblet cells, enteroendocrine cells and paneth 
cells by day 10.  
Stem cell marker Lgr5 was expressed at the base of the crypt-like buds of the 
enteroids (Figure 2A and F). Cell-cell adhesion marker: E-cadherin was expressed 
under all culture conditions, but was most highly expressed in the Matrigel to L-
pNIPAM enteroids (Figure 2B and G). Goblet cell marker MUC2 showed the 
presence of goblet cells and an adherent mucus layer covering the enteroids (Figure 
2C and H). The enteroendocrine cell marker: chromogranin A, showed 
immunopositive cells scattered throughout the enteroid structure (Figure 2D and I). 
Paneth cell marker for lysozymes, was seen at the base of the crypt-like buds, but 
only in those tissues cultured directly into L-pNIPAM hydrogel (Figure 2E); whilst 
enteroids which were grown in Matrigel and then moved to L-pNIPAM hydrogel 
showed a scattered distribution of lysosome positive cells throughout the enteroid 
(Figure 2J). 
Morphological assessment of the isolated Lgr5+ small intestinal stem cells 
suspended within Matrigel, or suspended in Matrigel for 7 days then 
dissociated and re-suspended in or layered on L-pNIPAM  
Single Lgr5+ intestinal cells (6.89 ± 0.56%) suspended within Matrigel formed 
enteroids after 5 days in culture. Between day 10 and 14, the enteroids formed 
numerous crypt-like buds (Figure 3). When Lgr5+ cells were grown in Matrigel for 7 
days, released, dissociated and cultured within or on L-pNIPAM hydrogel, they 
proliferated and started to form crypt-like buds. There was differentiation of these 
cells, and by day 7 goblet cells were seen, and by day 21 to 28 the enteroids were 
surrounded by an adherent mucus layer (Figure 4A & B).  
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Immunohistochemistry staining for differentiation markers of isolated Lgr5+ stem cells 
prior to L-pNIPAM 3D culture showed strong immunopositivity for Lgr5 and E 
cadherin, plus some low level chormogranin A and lysozome. There was no 
immunopositivity for MUC2 (Figure 5A). However, following culture in L-pNIPAM 
Lgr5 was expressed throughout the entire 28 day study period (Figure 5B & C). 
There were many Lgr5+ cells with the base of crypt-like buds at day 21 to 28. Cell-
cell adhesion marker E-cadherin was expressed at the later time points at day 21 
and 28. (Figure 6A & B). Lgr5+ intestinal stem cells were differentiated into mucin-
producing goblet cells. However, the expression of MUC2 was time-dependent, with 
the highest levels of MUC2 immunopositivity being observed at day 21 and 28 
(Figure 6C & D). Chromogranin-A immunopositivity which is indicative of the 
presence of enteroendocrine cells, was not consistantly observed and was effected 
by the culture conditions. When Lgr5+ intestinal stem cells were suspended within L-
pNIPAM hydrogel chromogranin-A expressed occurred at day 21 to 28 (Figure 7 A). 
However, when Lgr5+ intestinal stem cells were layered on L-pNIPAM hydrogel 
Chromogranin-A expression occurred at day 14 (Figure 7B). Lysozyme expression 
was seen between 7-28 days, indicating the differentiation of Paneth cells when 
suspended within or layered on L-pNIPAM hydrogel (Figure 7 C & D). However the 
highest expression was observed in the enteroids when layered on L-pNIPAM 
hydrogel (Figure 7 D).  
Discussion  
In vivo, intestinal stem cells are positioned at the base of the intestinal crypts and 
have the ability differentiate into multiple epithelial progenies and initiate mucosal 
regeneration[32]. Thus, intestinal stem cells hold great potential in tissue engineering 
and researchers worldwide are using these stem cells in conjunction with a variety of 
biomaterial and biological approaches in order to grow intestinal mucosa. A number 
of biomaterials including Matrigel, collagen type 1, PGA, PLA, PLGA have been 
investigated as potential cellular scaffolds [33-38].  Here we investigate the potential of 
a synthetic porous L-pNIPAM hydrogel as a 3D scaffold for enteroid development 
from crypts and Lgr5+ intestinal stem cells under dynamic culture conditions, when 
suspended within or layered on our hydrogel.  
3D culture system for intestinal crypts 
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Matrigel is a naturally derived 3D scaffold, rich in laminin and collagen, and is 
commonly used in in vitro culture. Its use in intestinal epithelial culture is well 
known[38] and it was the first system used to culture intestinal stem cells. Its high 
laminin content is thought to encourage cellular differentiation of intestinal crypt cells 
and supports villus formation[41]. Sato et al. (2009) developed an in vitro culture 
system capable of developing intestinal enteroids from isolated crypts and single 
Lgr5+ stem cells. These enteroids showed the presence of a central core lined with 
villus-like domains surrounded by crypt-like buds after only 14 days in culture. These 
crypt-like buds maintained the basic crypt morphology; however, the central core of 
the enteroid at the top of the crypts became filled with dead cells which were shed 
from the crypt villus domain[38]. This enteroid structure and accumulation of dead 
cells has been subsequently observed in a number of studies and is described as a 
cystic-enteroid [15, 18, 38]. Despite the potential advantages of Matrigel, particularly the 
similarity to native extracellular matrix; there are also a number of disadvantages, 
including limited stability for long term culture, low mechanical stiffness and high 
batch variation[42, 43]. Furthermore Matrigel is inappropriate for clinical applications as 
it is sourced from cancerous tissues (Engelbreth-Holm-Swarm mouse sarcoma) [42, 
43].  
Hence, these limitations have led to the use of synthetic scaffolds with well-defined 
biochemical and biophysical properties as a scaffold for intestinal tissue engineering 
[44-46]. This current study demonstrated that the synthetic highly porous L-pNIPAM 
hydrogel facilitated crypt cell seeding and adhesion. However, crypt-like buds were 
not observed when crypts were directly layered on the L-pNIPAM hydrogel surface. 
This suggests that there is some degree of in vitro conditioning required to support 
enteroid formation on the surface of the hydrogel. Nevertheless, when crypts were 
directly placed into the L-pNIPAM hydrogels, immunohistochemical staining did 
demonstrate the presence of Lgr5+ stem cells, enterocytes, goblet cells, 
enteroendocrine cells and Paneth cells; suggesting the ability of our hydrogel to 
support cellular survival and differentiation. Of note,  when crypts were suspended 
within Matrigel for 7 days prior to re-suspension within or layered on L-pNIPAM 
hydrogel for 10 days under dynamic culture conditions the enteroids had multiple 
crypt-like buds, containing mucin-secreting goblet cells. This suggests that isolated 
crypts require extracellular matrix signals to form enteroids with crypt-like buds. This 
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extracellular matrix may have orginiated from Matrigel culture, and despite 
substantial washes was still retained by the crypts; or alternatively was produced by 
the crypts during the 10 day culture period. Previous studies have also shown the 
requirement of an extracellular matrix such as Matrigel[45] or collagen type I[27] when 
using synthetic scaffolds to support intestinal crypt cultures [47]  Similarly, Matrigel 
was used to coat PLGA villus-moulds to support enteroid formation of co-cultured 
intestinal crypts, myofibroblasts and macrophages[45], Here, the cells were shown to 
differentiate into all the intestinal cell lineages, however they did not form true-villi, 
but instead produced an enteroid  in the shape of the villus-mould [45]. In contrast, our 
previous work has shown that monocultured or co-cultured human colon carcinoma 
cell lines Caco-2 and HT29-MTX cells grown on our L-pNIPAM hydrogel showed 
spontaneous formation of villus-like structures [28, 48].  
In the current study, our cultures demonstrated the early stages of enteroid formation 
and cellular differentiation and maintenance of cultures for upto the 28 days. It 
remains to be determined if longer term cultures would result in spontaneous villi 
formation, or whether transplantation of the L-pNIPAM enteroids in in vivo models 
may induce villi formation. This effect has been observed previously when enteroids 
grown on a PLGA scaffolds were transplantation in to in vivo systems [37, 49, 50]. 
LGR-5 Stem cell Culture 
Similar to crypt cultures, Matrigel has been used as a 3D culture system for intestinal 
stem cells [51]. The current study, found that the isolated Lgr5+ stem cells formed 
enteroids with multiple crypt-like buds when grown in Matrigel. These data agrees 
with a number of studies where enteroids were generated in Matrigel from single 
Lgr5+ stem cells after 5 days[18, 20, 29, 38, 52]. When enteroids were initially formed in 
Matrigel, then dissociated into single cells and suspended within or layered on L-
pNIPAM hydrogel, the stem cells generated crypt-like buds within 21 days, and 
expressed markers of enterocytes, mucus producing goblet cells, enteroendocrine, 
and Paneth cells, together with a residing population of Lgr5+ stem cells. This 
suggests that these Lgr5+ stem cells can be differentiated into the four main types of 
intestinal epithelial cells when suspended within or layered on L-pNIPAM hydrogel. 
However, it is unknown whether the cells released from the enteroid cultures grown 
in the Matrigel, were stem cells or differentiated intestinal cells. It has been shown 
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previously that enterocyte progenitors can become proliferative stem cells and 
Paneth-like cells during crypt regeneration, to replenish stem cell loss[53]. However in 
vivo enterocyte progenitors not only can dedifferentiate to stem cells, but also 
secretory progenitors, which derive from Lgr5+ stem cells and generate goblet cells, 
enteroendocrine cells and Paneth cells, which can then dedifferentiate back to stem 
cells, to replace lost stem cells[53]. Thus, the cells derived from the dissociated 
Matrigel enteroids could have been stem cells, or differentiated cells which then 
dedifferentiated to an earlier progenitor cell which then went on to form later 
enteroids in L-pNIPAM hydrogels, this requires further investigation. 
Gjorevski et al reported the first synthetic matrix for the expansion of mouse and 
human intestinal stem cells. They tested the effect of matrix mechanical properties 
on the stem cell survival, proliferation, expansion and differentiation. It was shown 
that varying stiffness of polyethylene glycol (PEG) hydrogel and extracellular matrix 
components were required for stem cell expansion and enteroid formation. 
Fibronectin based adhesion was required for intestinal stem cell survival and 
proliferation, whilst stem cell expansion required high matrix stiffness. Thus a soft 
matrix and laminin-based adhesion were required for both intestinal stem cell 
differentiation and enteroid formation[26]. The relationship between matrix stiffness 
and the intestinal crypt and stem cell behaviours can be seen in this study. The 
Matrigel which is relatively soft, having a young's modulus ˂ 500 Pa, supported 
enteroid formation, but not crypt-like buds or villus formation. Whilst the  L-pNIPAM 
hydrogel which is much stiffer with a storage modulus of  0.18-2.8 MPa[28] supported  
intestinal crypts and stem cells survival, differentiation and enteroid formation under 
dynamic culture conditions.  
These findings are in agreement with our previous study which demonstrated the 
potential of L-pNIPAM hydrogel to maintain, differentiate, and stimulate Caco-2 and 
HT29-MTX cells to form villus-like structures compared to low stiffness alginate, 
where the cells only formed spheroid-like structures under dynamic culture 
conditions[28]. Of note L-pNIPAM hydrogels were able to maintain enteroid cultures 
for the whole 28 days investigation period; this is problematic for Matrigel cultures 
due to low long term stability. Of particular interest would be the potential 
development of our synthetic L-pNIPAM hydrogel as a microcapsule delivery system 
similar to that reported for scalable production of organoids utilising a shell structure 
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of Matrigel and alginate using bioreactor systems for mass culture54. Due to the 
longer stability of our hydrogel the culture beyond the 6 days investigated in this prior 
study54 would be important to investigate.    
Conclusion 
L-pNIPAM hydrogel was a suitable scaffold to support the formation of enteroids in 
vitro following an initial priming culture in Matrigel from small intestinal crypts and 
Lgr5+ stem cells isolated from mice and supported appropriate cell differentiation. 
Further studies are now required to investigate the ability of L-pNIPAM hydrogel as a 
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Figure 1 (A) Bright-field morphology of the isolated small intestinal crypts 
suspended within Matrigel for 0-14 days. Representative organoids with black 
arrows indicating crypt buds. (B) Morphology of the isolated small intestinal 
crypts when suspended directly within or layered on L-pNIPAM hydrogel 
under dynamic culture conditions for 14 days. The cells stained with H&E AB-
PAS. Black arrows indicate mucin-producing goblet cells. (C) Morphology of the 
isolated small intestinal crypts when suspended within Matrigel for 7 days then 
the derived organoids were released from Matrigel and dissociated into small 
fragments and then re-suspended within or layered on L-pNIPAM hydrogel 
under dynamic culture conditions for 10 days. Stained with H&E: the black 
arrows indicate the crypt-like buds and AB-PAS: the black arrows indicate 








Figure 2 Immunohistochemistry staining (black arrows) for Lgr5, E-cadherin, 
MUC2, Chromogranin-A, and Lysozyme of the isolated small intestinal crypts: A-E 
suspended directly within L-pNIPAM hydrogel under dynamic culture conditions 
for 10 days; F-J suspended within Matrigel for 7 days then the organoids were 
released from Matrigel and dissociated into small fragments then suspended within 
L-pNIPAM hydrogel under dynamic culture conditions for 10 days. Cell nuclei 















Figure 3 Bright-field morphology of the isolated Lgr5
+ 
intestinal stem cells 
suspended within Matrigel from day 0 to 14. Black arrows indicate organoid 








Figure 4 Morphology of the isolated Lgr5
+ 
intestinal stem cells suspended within 
Matrigel for 7 days then the organoids were released from Matrigel and 
dissociated into single cells and (A) were suspended in L-pNIPAM hydrogel or 
(B) were layered on L-pNIPAM hydrogel under dynamic culture conditions for 
7 to 28 days. Cells were stained with H&E and AB-PAS. The black arrows 













Figure 5 Immunohistochemistry staining for (A) Lgr5; E-cadherin; MUC2; 
Chromogranin-A and Lysozymes in cytospin of the isolated Lgr5
+
 intestinal 
stem cells. (B) Lgr5 expression in isolated Lgr5
+ 
intestinal stem cells when 
suspended within Matrigel for 7 days then the organoids were released from 
Matrigel and dissociated into single cells then suspended within L-pNIPAM 
hydrogel or layered on L-pNIPAM hydrogel under dynamic culture conditions 
for 7 to 28 days. Cell nuclei were stained with haematoxylin (blue). Scale bar = 
20 µm. Cell nuclei were stained with haematoxylin (blue). Scale bar (A) 100 µm, 










Figure 6 Immunohistochemistry staining (black arrows) for E-cadherin (A&B) 
and MUC2 (C&D) of the isolated Lgr5
+
 intestinal stem cells suspended within 
Matrigel for 7 days then the organoids were released from Matrigel and 
dissociated into single cells and suspended within L-pNIPAM hydrogel or 
layered on L-pNIPAM hydrogel under dynamic culture conditions for 7 to 28 









Figure 7 Immunohistochemistry staining (black arrows) for chromogranin A 
(A&B) and lysozyme (C&D) of the isolated Lgr5
+
 intestinal stem cells suspended 
within Matrigel for 7 days then the organoids were released from Matrigel and 
dissociated into single cells and suspended within L-pNIPAM hydrogel or 
layered on L-pNIPAM hydrogel under dynamic culture conditions for 7 to 28 
days. Cell nuclei were stained with haematoxylin (blue). Scale bar = 20 µm.  
